TRUIST FINANCIAL CORP

Position in RPRX — Royalty Pharma plc

CIK 92230 CHARLOTTE, NC

Position in RPRX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$1,396,310

+$323,316 QoQ

Shares Held

29,108

+4.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

TRUIST FINANCIAL CORP holds $112,535,820 across 48 Biotechnology names. RPRX ranks #8 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	114,449	$51,106,055
2	REGN	Regeneron Pharmaceuticals, Inc.	40,108	$30,989,044
3	ARGX	Argenx SE	3,878	$2,831,908
4	ALNY	Alnylam Pharmaceuticals, Inc.	7,701	$2,548,029
5	INSM	INSMED Inc	15,416	$2,520,822
6	JAZZ	Jazz Pharmaceuticals plc	10,207	$1,929,631
7	EXEL	Exelixis, Inc.	32,818	$1,407,563
8	RPRX	Royalty Pharma plc This page	29,108	$1,396,310

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,396,310	29,108	+4.8%	Shares	Defined	2026-04-27
2025-12-31	$1,072,994	27,769	+1.1%	Shares	Defined	2026-02-02
2025-09-30	$969,000	27,466	+12.8%	Shares	Defined	2025-11-03
2025-06-30	$876,934	24,339	+3.6%	Shares	Defined	2025-07-18
2025-03-31	$731,305	23,492	+61.6%	Shares	Defined	2025-04-29
2024-12-31	$370,889	14,539	+7.8%	Shares	Defined	2025-01-31
2024-06-30	$355,625	13,486	-43.1%	Shares	Defined	2024-08-21
2024-03-31	$719,676	23,697	+50.1%	Shares	Defined	2024-05-13
2023-12-31	$443,484	15,788	-59.2%	Shares	Defined	2024-02-02
2023-03-31	$1,395,477	38,731	+1.3%	Shares	Defined	2023-05-05
2022-12-31	$1,511,442	38,245	-18.5%	Shares	Defined	2023-02-17
2022-09-30	$1,885,567	46,928	+265.9%	Shares	Defined	2022-10-26
2022-06-30	$539,163	12,825	—	Shares	Defined	2022-07-22
No filing history on record for this holder in this stock.